ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) concluded the trading at $0.53 on Friday, January 10 with a fall of -2.85% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.54 and 5Y monthly beta was reading 0.273 with its price kept floating in the range of $0.5071 and $0.58 on the day. Considering stock’s 52-week price range provides that IPA hit a high price of $2.60 and saw its price falling to a low level of $0.32 during that period. Over a period of past 1-month, stock came adding 25.95% in its value.
With its current market valuation of $16.42 million, ImmunoPrecise Antibodies Ltd is set to declare its quarterly results in February. Analysts are in estimates of 0 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to 0 for current year with estimates of that growing to 0 in next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of 6.58M. They suggested that in the process company could generate revenue of as low as 6.2M which could climb up to 6.97M to hit a high. The average estimate is representing an increase of 5.85% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of 24.74M in current fiscal year, which will be 0.92% more from revenue generated by the company last year.
In contrast, when we review IPA stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of 50% Sell. Long term indicators are suggesting an average of 100% Sell for it.
Digging deeper we become aware of the PEG ratio of the IPA stock which is currently positioned at 0. It further provides that stock’s current price level is 19.15% away from its 20-day simple moving average and is 23.53% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 66.35 while volatility remained at 15.32% over the past week which changes to 11.68% when measuring it over the past month. Beta is valued at 0.18, while measure of average true range or ATR is currently at 0.05.
Having a second look at ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) provides that stock’s average daily trading volume for 3 months was 574.14K, while it jumped to 434970 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 30.29 million.
The percentage of outstanding shares held by the insiders is 19.92% while it is 7.71% for the institutional holders. The figures also indicate that as of 2024-11-15, number of stock’s short shares was 0.69 million which implies a short ratio of 0.7. This shows up a 241.00 of Short Interest in company’s outstanding shares on the day. In November the standing of shares short improved as it was 0.15 million in the previous month. Addition of 28.37% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
